Fig. 6From: Melanoma genome evolution across speciesPathway analysis of the G-protein, cAMP/PKA signaling alterations found in the ZMEL-R1 cells. This pathway diagram predicts reactivation of MAP kinase signaling through this pathway, which accounts for the resistance to the BRAF inhibitor vemurafenibBack to article page